News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,576 Results
Type
Article (68592)
Company Profile (376)
Press Release (685588)
Multimedia
Podcasts (166)
Webinars (30)
Section
Business (205666)
Career Advice (2670)
Deals (34219)
Drug Delivery (129)
Drug Development (84728)
Employer Resources (161)
FDA (16860)
Job Trends (15080)
News (348816)
Policy (32442)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2952)
Academic (2)
Accelerated approval (37)
Adcomms (24)
Allergies (159)
Alliances (53106)
ALS (189)
Alzheimer's disease (1799)
Antibody-drug conjugate (ADC) (369)
Approvals (17109)
Artificial intelligence (621)
Autoimmune disease (181)
Automation (46)
Bankruptcy (319)
Best Places to Work (11746)
BIOSECURE Act (21)
Biosimilars (189)
Biotechnology (254)
Bladder cancer (167)
Brain cancer (67)
Breast cancer (682)
Cancer (5226)
Cardiovascular disease (447)
Career advice (2250)
Career pathing (40)
CAR-T (306)
CDC (52)
Celiac Disease (1)
Cell therapy (839)
Cervical cancer (39)
Clinical research (71785)
Collaboration (1930)
Company closure (5)
Compensation (1148)
Complete response letters (67)
COVID-19 (2944)
CRISPR (105)
C-suite (948)
Cystic fibrosis (149)
Data (6626)
Decentralized trials (2)
Denatured (63)
Depression (156)
Diabetes (526)
Diagnostics (6952)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (43)
Drug discovery (300)
Drug pricing (182)
Drug shortages (27)
Duchenne muscular dystrophy (244)
Earnings (85525)
Editorial (62)
Employer branding (20)
Employer resources (146)
Events (118946)
Executive appointments (1051)
FDA (20171)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1604)
Gene editing (224)
Generative AI (61)
Gene therapy (682)
GLP-1 (1057)
Government (4767)
Grass and pollen (7)
Guidances (386)
Healthcare (19324)
HIV (67)
Huntington's disease (51)
IgA nephropathy (89)
Immunology and inflammation (285)
Immuno-oncology (71)
Indications (132)
Infectious disease (3244)
Inflammatory bowel disease (213)
Inflation Reduction Act (17)
Influenza (130)
Intellectual property (265)
Interviews (483)
IPO (16320)
IRA (55)
Job creations (3712)
Job search strategy (1883)
JPM (66)
Kidney cancer (19)
Labor market (80)
Layoffs (588)
Leadership (41)
Legal (7250)
Liver cancer (98)
Longevity (18)
Lung cancer (703)
Lymphoma (388)
Machine learning (46)
Management (55)
Manufacturing (869)
MASH (180)
Medical device (14038)
Medtech (14101)
Mergers & acquisitions (19040)
Metabolic disorders (1359)
mRNA (189)
Multiple sclerosis (175)
NASH (20)
Neurodegenerative disease (365)
Neuropsychiatric disorders (103)
Neuroscience (3174)
Neurotech (1)
NextGen: Class of 2026 (6710)
Non-profit (4731)
Now hiring (57)
Obesity (630)
Opinion (330)
Ovarian cancer (174)
Pain (219)
Pancreatic cancer (250)
Parkinson's disease (312)
Partnered (38)
Patents (534)
Patient recruitment (545)
Peanut (63)
People (60948)
Pharmaceutical (82)
Pharmacy benefit managers (24)
Phase 1 (22516)
Phase 2 (31476)
Phase 3 (23448)
Pipeline (5981)
Policy (297)
Postmarket research (2859)
Preclinical (10047)
Press Release (72)
Prostate cancer (271)
Psychedelics (56)
Radiopharmaceuticals (315)
Rare diseases (961)
Real estate (6224)
Recruiting (70)
Regulatory (25205)
Reports (42)
Research institute (2707)
Resumes & cover letters (416)
Rett syndrome (30)
RNA editing (20)
RSV (84)
Schizophrenia (163)
Series A (270)
Series B (206)
Service/supplier (15)
Sickle cell disease (106)
Special edition (26)
Spinal muscular atrophy (169)
Sponsored (47)
Startups (3891)
State (1)
Stomach cancer (20)
Supply chain (109)
Tariffs (71)
The Weekly (101)
Vaccines (1129)
Venture capital (93)
Weight loss (416)
Women's health (97)
Worklife (22)
Date
Today (180)
Last 7 days (924)
Last 30 days (2924)
Last 365 days (31316)
2026 (5263)
2025 (31565)
2024 (36469)
2023 (41301)
2022 (52623)
2021 (57036)
2020 (55219)
2019 (47668)
2018 (36067)
2017 (34210)
2016 (34030)
2015 (40211)
2014 (33448)
2013 (29521)
2012 (30296)
2011 (30507)
2010 (28798)
Location
Africa (996)
Alabama (95)
Alaska (6)
Arizona (286)
Arkansas (15)
Asia (45190)
Australia (7874)
California (11843)
Canada (3382)
China (1209)
Colorado (492)
Connecticut (515)
Delaware (352)
Europe (103834)
Florida (1788)
Georgia (375)
Hawaii (3)
Idaho (55)
Illinois (900)
India (77)
Indiana (535)
Iowa (22)
Japan (464)
Kansas (132)
Kentucky (43)
Louisiana (28)
Maine (83)
Maryland (1475)
Massachusetts (8587)
Michigan (364)
Minnesota (659)
Mississippi (6)
Missouri (135)
Montana (36)
Nebraska (29)
Nevada (128)
New Hampshire (80)
New Jersey (3174)
New Mexico (33)
New York (3120)
North Carolina (1582)
North Dakota (10)
Northern California (5788)
Ohio (359)
Oklahoma (23)
Oregon (44)
Pennsylvania (2347)
Puerto Rico (21)
Rhode Island (45)
South America (1285)
South Carolina (70)
South Dakota (1)
Southern California (4608)
Tennessee (176)
Texas (1835)
United States (42201)
Utah (359)
Vermont (1)
Virginia (295)
Washington D.C. (82)
Washington State (975)
West Virginia (4)
Wisconsin (134)
Wyoming (2)
754,576 Results for "biomedical advanced research and development authority barda".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
February 25, 2026
·
5 min read
Press Releases
GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance artificial intelligence-powered ultrasound for trauma care and emergency preparedness
February 17, 2026
·
3 min read
Press Releases
CROSSJECT Secures Additional BARDA Funding for the Progressive Developmental and FDA Authorization of the ZEPIZURE® (ZENEO® Midazolam)
September 22, 2025
·
2 min read
Press Releases
Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10
February 18, 2026
·
5 min read
Press Releases
Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting
January 29, 2026
·
5 min read
Press Releases
Paratek Pharmaceuticals Announces Positive Results for NUZYRA® Therapeutic Efficacy Studies in Inhalation Anthrax Triggering Additional Procurement under BARDA Project BioShield Contract
February 24, 2026
·
6 min read
Vaccines
RFK Jr. Axes 22 mRNA Vaccine Projects Under BARDA
The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA vaccine development, a move that will affect several pharma companies, including Moderna, Pfizer, Sanofi and AstraZeneca.
August 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies
December 12, 2025
·
2 min read
Press Releases
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium
November 5, 2024
·
6 min read
Press Releases
Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study
December 2, 2025
·
11 min read
1 of 75,458
Next
